Correctional Services - Medication Review Committee - Administration of Psychotropic Medication to an Incarcerated Individual
HB0279 authorizes the Department of Public Safety and Correctional Services to establish a medication review committee to decide whether psychotropic medication may be administered on a nonemergency basis to an incarcerated individual who refuses it. The bill applies only in mental health care facilities within state correctional facilities for individuals convicted of crimes and sentenced to the Division of Correction. It sets out the circumstances under which involuntary medication may be approved, including findings that the person has a mental disorder, lacks capacity to consent, poses a serious danger to self or others, and that less restrictive alternatives have been considered or tried.
The bill creates a detailed procedural framework for committee review. It specifies committee membership, requires notice to the incarcerated individual and relevant representatives, provides for a lay advisor, allows the individual to attend part of the meeting and present evidence, and requires a written decision. It also establishes administrative review and judicial appeal rights, limits approvals to 90 days, requires periodic documentation by treating providers, and mandates annual reporting to the Maryland Department of Health on committee activity and forced medication use. The bill also includes protections limiting the use of statements made during the process and restricts restraints and seclusion in mental health care facilities.
HB0279 would add a new section to the Correctional Services Article, creating a statutory process for involuntary psychotropic medication in state correctional mental health facilities. It would affect incarcerated individuals in the Division of Correction, correctional mental health providers, the Department of Public Safety and Correctional Services, the Office of Administrative Hearings, and the circuit courts by establishing new review, appeal, documentation, and reporting obligations. The bill also interacts with existing mental health and administrative law procedures by incorporating due process protections and requiring annual data reporting to the Maryland Department of Health.
The available context suggests the bill moved forward without recorded opposition in the provided materials, and it received a favorable committee report with amendments in the House. The bill’s structure indicates an effort to balance treatment authority with procedural safeguards, which may have helped support it. No committee transcript or vote record is provided here, so broader debate cannot be directly assessed from the supplied context.
The main point of contention inherent in the bill is the authorization of involuntary psychotropic medication for incarcerated individuals who refuse treatment, especially in nonemergency situations. Potential concerns include civil liberties, informed consent, due process, the role of correctional medical staff in initiating forced treatment, and whether the standards for danger, incapacity, and necessity are sufficiently strict. The bill addresses these concerns by adding notice, lay advocacy, hearing, appeal, and reporting requirements, suggesting that supporters prioritized safeguards while critics would likely focus on the coercive nature of the intervention.